About Event
The 5th Gene Therapy Analytical Development Europe – What Did You Miss?
In the face of evolving regulatory guidelines and mounting scrutiny, the 5th Gene Therapy Analytical Development Europe Summit discussed ways you can apply contemporary analytical tools to guarantee the consistency, quality, and safety of your gene therapy products.
We joined leading CMC, regulatory, QC, analytical and process development experts to gain access to novel data and recent case studies by industry professionals from AstraZeneca, the MHRA, Novartis, Sarepta Therapeutics, Roche, Sanofi, and many more.
What Previous Attendees Have to Say:
'Very relevant talks from a range of very experienced speakers’
James Norton, Meira GTx
'Network communication was very impressive, and the topics are very meaningful and helpful’
Jiachi Liu, Neurophth Therapeutics
Very specific and accurate meeting, which deals with the subjects in a very complete way’
Nicole Brument, Coave Therapeutics
'Speed dating gives opportunity to meet lots of participants in short time at the beginning of the conference. I enjoyed it!’
Polona Kogovsek, National Institute of Biology